Daniel Antonio Perez, the CEO and co-founder of Hinge Health, Inc., has recently reported a series of stock transactions involving both Class A and Class B shares of the company. This update is significant as it highlights changes in ownership and could impact investor confidence in the leadership of the health technology firm.
Hinge Health, based in San Francisco, operates within the services sector, specifically focusing on computer processing and data preparation. The company has been actively filing with the SEC, with its most recent filing dated October 7, 2026, detailing Perez's stock transactions.
Details of the Filing
The SEC filing reveals that on October 6, 2026, Perez acquired 4,100 shares of Class A Common Stock and simultaneously disposed of another 4,100 shares at a weighted average price of $100.1978. Following these transactions, Perez retains ownership of 9,774,572 shares of Class B Common Stock, which are convertible into Class A shares. The filing states, "The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and his spouse on June 11, 2026." This indicates a pre-arranged plan for trading, which is often used to avoid allegations of insider trading.
Impact of the Transactions
These transactions may affect various stakeholders, including investors, employees, and competitors. Investors might view the transactions as a sign of confidence from Perez in the company's future, especially given the structured nature of the trades. Employees might interpret this as a positive signal regarding the leadership's commitment to the company's growth. Competitors in the health technology sector may also observe these developments closely, as they could reflect broader trends in executive ownership and stock management within the industry.
What's Next?
The filing does not say what happens next regarding additional transactions or changes in ownership. However, it is clear that Perez remains a significant shareholder in Hinge Health, which could influence the company's strategic direction moving forward.